Royce & Associates LP raised its position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 0.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 442,257 shares of the biopharmaceutical company’s stock after purchasing an additional 3,071 shares during the period. Royce & Associates LP owned 0.35% […]